Cart (0 Items)
Your cart is currently empty.
View Products-
-
-
Actoxumab Biosimilar – Anti-toxin A mAb – Research Grade
| Size | 100ug, 1MG |
|---|---|
| Isotype | IgG1, kappa |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Actoxumab Biosimilar - Anti-toxin A mAb - Research Grade |
|---|---|
| Source | CAS 1245634-25-6 |
| Species | Homo sapiens |
| Expression system | Mammalian cells |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Actoxumab,CDA 1,MBL-CDA1,MDX-066,MK-3415A (combination of actoxumab and bezlotoxumab),toxin A,anti-toxin A |
| Reference | PX-TA1285 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG1-kappa |
| Clonality | Monoclonal Antibody |
Description of Actoxumab Biosimilar - Anti-toxin A mAb - Research Grade
General information on Anti-toxin A[Clostridium difficile] (Actoxumab) Monoclonal Antibody
Actoxumab has been investigated for the treatment of Clostridium Difficile Infections.
Contact us
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.
Reviews
There are no reviews yet.